Navigation Links
Strong Endorsements cited for MedQIA - Imaging CRO's Novel Bone Scan Scoring System at the ASCO 2012 Annual Meeting
Date:7/3/2012

LOS ANGELES, July 3, 2012 /PRNewswire/ -- MedQIA has developed a bone scan analysis package within our 510 (k) – cleared Imaging Biomarker Information System (IBIS). It includes a new automated technique for detecting lesions on bone scans that involves intensity normalization, thresholding, and connected-component analysis. The system calculates quantitative metrics for assessing disease burden and treatment response including total Bone Scan Lesion Area (BSLA), Bone Scan Lesion Intensity (BSLI), and Bone Scan Lesion Count (BSLC).1) During the breakout Oral Session for Prostate Cancer,  Karim Fizazi, MD, Ph.D., of the Institute Gustavo Roussy stated the following: "I would like to emphasize that we now have a new computer assisted detection system available for response in bone scan and I think this is a very important landmark for research in prostate cancer, because it is so difficult to measure response and progression in that disease."2) During the Poster Discussion Session for Genitourinary (Prostate ) Cancer, Ulka Vaishampayan, MD,  stated:"This methodology should be encouraged for future evaluation of novel agents since it lets you keep the efficacy without compromising and continuing to reduce toxicities."This automated system allows for reproducible quantification of metastases in bone scans and reliable interpatient and intrapatient comparison. It has been established as an objective measurement of treatment effects. Trials are ongoing that include validation against other clinically relevant outcome measures.

About MedQIA

MedQIA is a full service Imaging CRO that specializes in Computer Vision systems for automated image analysis and measurement. Computer-calculated imaging biomarkers are more accurate, sensitive, and reproducible than manual human measurements. This results in shorter trials with fewer subjects and enables adaptive study designs. What sets us apart is our ability to develop and validate novel imaging biomarkers for use in global, regulated clinical trials.

MedQIA provides a full range of core laboratory services and handles all aspects of your clinical trial from planning to completion.

We offer our services worldwide with regional offices in the US, Australasia and Europe.

For more information please visit our website at www.medqia.com

Contact Information: Juliette Bridges, MS, MBA – Business Development Manager: jbridges@medqia.com
-888-963-3742


'/>"/>
SOURCE MedQIA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Need for Reduced Healthcare Outlays Creates Strong Growth Potential for Medical Imaging Services, Says Frost & Sullivan
2. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
3. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
4. Strong Booking Levels For Informex 2013
5. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
6. Stereotaxis Epochâ„¢ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
7. GP Strategies Reports Strong First Quarter 2012 EPS of $0.23
8. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
9. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
10. Global Imaging Agents Industry
11. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/27/2017)... --  NuEyes (NuEyes Technologies Inc.) today announced that it ... in helping the legally blind live more independent lives. NuEyes works ... developer of augmented, virtual and mixed reality smartglasses and the ... funding amount was provided by strategic partners as well as ... Abu Dhabi , New York ...
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology:
(Date:6/28/2017)... British Columbia (PRWEB) , ... June 28, 2017 ... ... CNZCF) (FSE: ZEON) is pleased to announce that a two year study conducted ... the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As ...
(Date:6/28/2017)... OH (PRWEB) , ... June 28, 2017 , ... ... of Hamilton County and the surrounding regions access to insurance assistance and financial ... with Matthew 25: Ministries to assist families in the region facing financial crisis. ...
(Date:6/28/2017)... Cincinnati, OH (PRWEB) , ... June 28, 2017 ... ... and financial consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is ... help provide temporary lodgings for families with children receiving treatment in nearby hospitals. ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 ... survey data released today by the American Society for Dermatologic Surgery ... the percentage of consumers considering a cosmetic medical procedure has doubled since 2013. ...
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
Breaking Medicine News(10 mins):